Covid Vaccines Effective Against Variant From India, Study Finds
- Pfizer and AstraZeneca doses shown to work by U.K.’s PHE
- Results likely to boost case for lifting U.K. lockdown in June
This article is for subscribers only.
Coronavirus vaccines from Pfizer Inc. and AstraZeneca Plc have been shown to work against a variant first identified in India, according to a study by Public Health England.
Two doses of the Covid-19 vaccines were “highly effective” against the B.1.617.2 strain first detected in India, the agency said in a statement. There was minimal difference with how the inoculations work on a variant detected in Kent, it said.